|Download document||Draft reflection paper on the use of patient reported outcome (PRO) measures in oncology studies|
|Status||draft: consultation open|
|Consultation start date||17/06/2014|
|Consultation end date||30/11/2014|
|Email address for email@example.com|
The importance of the patient’s point of view on their health status is fully acknowledged and such information may in principle be used in drawing regulatory conclusions regarding treatment effects. This reflection paper on the use of patient reported outcome (PRO) measures in patients with malignancies focuses on the value of these data from a regulatory perspective.